US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

Is a

Patent

Patent attributes

Patent Applicant

Avidity Biosciences

Current Assignee

Avidity Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

117124780

Date of Patent

August 1, 2023

Patent Application Number

174997960

Date Filed

October 12, 2021

Patent Citations

‌

US Patent 7432250 Oligoribonucleotides and ribonucleases for cleaving RNA

‌

US Patent 7452987 Interfering RNA molecules

‌

US Patent 7459547 Methods and compositions for controlling efficacy of RNA silencing

‌

US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands

‌

US Patent 7521232 Emissive species for clinical imaging

‌

US Patent 7595387 Modified polynucleotides for reducing off-target effects in RNA interference

‌

US Patent 7629321 Oligoribonucleotides and ribonucleases for cleaving RNA

‌

US Patent 7691997 Functional and hyperfunctional siRNA

...

Patent Primary Examiner

‌

Kimberly Chong

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy